VRK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.286000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.427800E-01
Normal-vs-Stage2
5.030600E-01
Normal-vs-Stage3
2.641000E-01
Normal-vs-Stage4
5.854800E-01
Stage1-vs-Stage2
4.970000E-01
Stage1-vs-Stage3
5.247200E-01
Stage1-vs-Stage4
6.004800E-01
Stage2-vs-Stage3
2.674000E-01
Stage2-vs-Stage4
9.205400E-01
Stage3-vs-Stage4
2.799000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.918800E-01
Normal-vs-AfricanAmerican
2.308000E-01
Normal-vs-Asian
2.587600E-01
Caucasian-vs-AfricanAmerican
2.769800E-01
Caucasian-vs-Asian
2.911000E-01
AfricanAmerican-vs-Asian
7.533000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.506800E-01
Normal-vs-Female
5.492800E-01
Male-vs-Female
3.561800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.679000E-01
Normal-vs-Age(41-60Yrs)
3.675000E-01
Normal-vs-Age(61-80Yrs)
4.410800E-01
Normal-vs-Age(81-100Yrs)
8.512000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.791200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.556600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.112600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.316600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.332400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.073800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.419000E-01
Normal-vs-Daily Drinker
4.931400E-01
Normal-vs-Weekly Drinker
7.575000E-01
Normal-vs-Occasional Drinker
6.231800E-01
Normal-vs-Social Drinker
2.690400E-01
Non Drinker-vs-Daily Drinker
7.925800E-01
Non Drinker-vs-Weekly Drinker
9.662400E-01
Non Drinker-vs-Occasional Drinker
6.779800E-01
Non Drinker-vs-Social Drinker
4.649000E-01
Daily Drinker-vs-Weekly Drinker
8.385600E-01
Daily Drinker-vs-Occasional Drinker
9.280200E-01
Daily Drinker-vs-Social Drinker
6.697200E-01
Weekly Drinker-vs-Occasional Drinker
7.934800E-01
Weekly Drinker-vs-Social Drinker
6.453000E-01
Occasional Drinker-vs-Social Drinker
6.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.893400E-01
Normal-vs-Grade 2
8.498400E-01
Normal-vs-Grade 3
8.488600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.570210E-01
Grade 1-vs-Grade 3
2.388800E-01
Grade 1-vs-Grade 4
7.893400E-01
Grade 2-vs-Grade 3
9.771400E-01
Grade 2-vs-Grade 4
8.498400E-01
Grade 3-vs-Grade 4
8.488600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.595200E-01
Normal-vs-NonDiabetic
3.432000E-01
Diabetic-vs-NonDiabetic
5.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.929800E-01
Normal-vs-NoPancreatitis
4.634200E-01
Pancreatitis-vs-NoPancreatitis
7.105000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.771200E-01
Normal-vs-N1
4.523000E-01
N0-vs-N1
8.992400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.204400E-01
Normal-vs-TP53-NonMutant
4.261800E-01
TP53-Mutant-vs-TP53-NonMutant
3.580000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
